Meeting
2020 ASCO Virtual Scientific Program
Phase I trial of hafnium oxide nanoparticles activated by radiotherapy in cisplatin-ineligible locally advanced HNSCC patients.
Authors
Christophe Le Tourneau
Institut Curie, Saint-Cloud, France
Christophe Le Tourneau , Valentin Calugaru , Edith Borcoman , Victor Moreno , Emiliano Calvo , Xavier Liem , Sebastien Salas , Bernard Doger , Olivier Choussy , Maria Lesnik , Xavier Mirabel , Nathalie Badois , Samar Krhili , Josefin Blomkvist , Nicolas Fakhry , Stéphanie Wong-Hee-Kam , Caroline Hoffmann
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Head and Neck Cancer
Track
Head and Neck Cancer
Sub Track
Local-Regional Disease
Clinical Trial Registration Number
NCT01946867
Citation
J Clin Oncol 38: 2020 (suppl; abstr 6573)
DOI
10.1200/JCO.2020.38.15_suppl.6573
Abstract #
6573
Poster Bd #
234
Abstract Disclosures
Similar Posters
Poster
2021 ASCO Annual Meeting
Phase I study of functionalized hafnium oxide nanoparticles (NBTXR3) activated by radiotherapy in cisplatin-ineligible locally advanced HNSCC patients.
First Author: Christophe Le Tourneau
Poster
2016 ASCO Annual Meeting
A phase I study of metformin in combination with cisplatin and radiation in locally advanced head and neck squamous cell carcinoma.
First Author: Trisha Michel Wise-Draper
Poster
2014 ASCO Annual Meeting
Phase I trial of cetuximab, intensity modulated radiotherapy (IMRT), and the anti-CTLA-4 monoclonal antibody (mAb) ipilimumab in previously untreated, locally advanced head and neck squamous cell carcinoma (PULA HNSCC).
First Author: Julie E. Bauman
Poster
2014 ASCO Annual Meeting
Randomized phase II trial of weekly paclitaxel, carboplatin, cetuximab (PCC) versus cetuximab, docetaxel, cisplatin, and fluorouracil (C-TPF) in previously untreated patients with locally advanced head and neck squamous cell carcinoma.
First Author: Erminia Massarelli